Peptide Synthesis Market Size, Growth, Market Analysis, Segmentation, And Forecast To 2033

The peptide synthesis market size has grown strongly in recent years. It will grow from $5.22 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization..

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rapid growth in therapeutic peptides, increasing demand for customized peptides, growing role in drug discovery and development, focus on peptide libraries for screening.. Major trends in the forecast period include development of peptide mimetics, adoption of novel amino acid derivatives, peptide cyclization techniques, innovations in solid-phase peptide synthesis (spps), utilization of click chemistry..

Market Overview -
Peptide synthesis refers to the laboratory process of producing peptides, which are compounds that are short chains of amino acids linked together by chemical bonds. These synthesized peptides have various applications in research, drug development, and medical diagnostics to generate precise sequences that mimic epitopes within particular protein domains.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

Rising Incidence Of Chronic Diseases Boosts Growth In The Peptide Synthesis Market
Growing chronic diseases are expected to propel the growth of the peptide synthesis market going forward. Chronic diseases refer to illnesses or non-communicable diseases (NCDs) that are long-term health conditions that persist over an extended period and often progress gradually. Peptide synthesis can be used for chronic diseases as some peptides exert anti-inflammatory and antioxidant activity, which could aid in the prevention of chronic diseases, including cardiovascular diseases. Peptides can address the fundamental causes of chronic disease by targeting particular cellular processes and signaling pathways, opening up novel therapeutic and management options. For instance, in August 2023, according to the data published by the British Heart Foundation, a UK-based non-profit organization, the number of deaths caused by coronary heart disease in the UK increased to 65,579 in 2021, compared with 64,170 in 2020. Therefore, the growing number of chronic diseases is driving the growth of the peptide synthesis market.

Competitive Landscape -
Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

Advancing Next-Generation Peptide Synthesizers To Gain A Competitive Edge
Major companies operating in the peptide synthesis market are focusing on introducing next-generation peptide synthesizers such as PurePep Sonata+ to gain a competitive edge in the market. PurePep Sonata+ is an advanced peptide synthesizer that offers improved efficiency, speed, and accuracy compared to traditional peptide synthesizers. For instance, in March 2022, Gyros Protein Technologies, a US-based peptide synthesis and bioanalytical technology services company, introduced the PurePep Sonata+ peptide synthesizer. PurePep Sonata+ extends the capabilities of Sonata XT by incorporating real-time flow technology. This innovative approach enables continuous monitoring of fluid flow rates within the system, providing a non-invasive means to ensure precise and accurate fluid transfers for a diverse range of viscosities.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Key Segments -
The peptide synthesis market covered in this report is segmented -
1) By Product And Service: Reagents, Equipment, Services
2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.